RPR Gencell other research news

Gencell and collaborators in France and Denmark have demonstrated increased survival using delivery of the genes for NT-3 and CNTF

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE